Hemorrhagic Fever - 27 Studies Found
Completed |
: STRIVE (Sierra Leone Trial to Introduce a Vaccine Against Ebola) : Hemorrhagic Fever, Ebola : 2015-02-19 : Biological: rVSVΔG-ZEBOV The rVSVΔG-ZEBOV vaccine is comprised of a single recombinant VSV iso |
Completed |
: Phase I Trial to Assess the Safety, Tolerability and Immunogenicity of a Ebola Virus Vaccine (rVSVΔG-ZEBOV-GP) : Hemorrhagic Fever, Ebola : 2014-10-31 : Biological: rVSVΔ-ZEBOV-GP single dose of rVSVΔ-ZEBOV-GP (3x10^6 pfu, 2x10^7 pfu or 3x10^5) |
Recruiting |
: Safety, Tolerability and Immunogenicity Study of 3 Prime-boost Regimens for Ebola Vaccines Ad26.ZEBOV/MVA-BN-Filo in Healthy Adults, Children and Human Immunodeficiency Virus Positive (HIV+) Adults : Hemorrhagic Fever, Ebola : 2015-09-29 :
|
Completed |
: A Study to Assess the Safety, Tolerability and Pharmacokinetics of AVI-7288 in Healthy Adult Volunteers : Marburg Hemorrhagic Fever : 2012-03-27 :
|
Completed |
: Safety Study of Single Administration Post-exposure Prophylaxis Treatment for Marburg Virus : Marburg Hemorrhagic Fever : 2011-04-22 :
|
Completed |
: Evaluating the Safety of and Immune Response to a Human Parainfluenza Virus Type 3 Ebola Virus Vaccine (HPIV3-EbovZ GP) in Healthy Adults : Hemorrhagic Fever, Ebola : 2015-09-29 : Biological: HPIV3-EbovZ GP Vaccine Administered intranasally by a VaxINator device |
Completed |
: Emergency Evaluation of Convalescent Plasma for Ebola Viral Disease (EVD) in Guinea : Hemorrhagic Fever, Ebola : 2015-01-12 : Other: Convalescent Plasma Patients will be treated with plasma from recovered EVD patients. |
Completed |
: Activated Recombinant Human Factor VII in Patients With Dengue Haemorrhagic Fever :
: 2012-05-14 :
|
Completed |
: Experimental Ebola Vaccine Trial :
: 2003-11-04 : Drug: VRC-EBODNA012-00-VP |
Not yet recruiting |
: African-Canadian Study of HIV-Infected Adults and a Vaccine for Ebola - ACHIV-Ebola : Ebola : 2016-12-22 :
|